Literature DB >> 27194675

First reported association of chronic lymphocytic leukaemia and interstitial granulomatous dermatitis.

Irbaz Bin Riaz1, Muhammad Umar Kamal2, Robert J Segal3, Faiz Anwer2.   

Abstract

Interstitial granulomatous dermatitis (IGD), a rare disease, is well known to be associated with connective tissue disorders, malignancies and several drugs. We describe this first case of IGD in association with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL). A 66-year-old woman with a 6-year history of untreated CLL/SLL, presented with a 2-month history of progressively worsening eruption of the left thigh, along with fatigue, lymphadenopathy and night sweats. Skin biopsy showed findings consistent with IGD and infiltration of CLL. The eruption was non-responsive to treatment with antibiotics and local steroids. There was a significant improvement in the rash after an initial cycle of chemotherapy (combination therapy with bendamustine and rituximab) and complete resolution by the third cycle, for the treatment of her CLL. We suggest that the possibility of an underlying haematological malignancy should be investigated in patients with a skin rash non-responsive to conventional therapy. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27194675      PMCID: PMC4885353          DOI: 10.1136/bcr-2016-215108

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.

Authors:  Wilma Barcellini; Silvana Capalbo; Rosa Maria Agostinelli; Francesca Romana Mauro; Achille Ambrosetti; Rossella Calori; Agostino Cortelezzi; Luca Laurenti; Enrico Maria Pogliani; Paola Pedotti; Vincenzo Liso; Gabriella Girelli; Franco Mandelli; Alberto Zanella
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

2.  Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia.

Authors:  Donald C Swing; Daniel J Sheehan; Omar P Sangüeza; R W Woodruff
Journal:  Am J Dermatopathol       Date:  2008-04       Impact factor: 1.533

3.  Interstitial granulomatous dermatitis associated with myelodysplastic syndrome - complete clearance under therapy with 5-azacytidine.

Authors:  Nikolaos Patsinakidis; Laura Susok; Schapoor Hessam; Nick Othlinghaus; Katrin Möllenhoff; Markus Stücker; Peter Altmeyer; Alexander Kreuter
Journal:  Acta Derm Venereol       Date:  2014-11       Impact factor: 4.437

4.  Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern.

Authors:  A Peroni; C Colato; D Schena; P Gisondi; G Girolomoni
Journal:  Br J Dermatol       Date:  2012-04       Impact factor: 9.302

Review 5.  Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies.

Authors:  L Verneuil; A Dompmartin; F Comoz; C J Pasquier; D Leroy
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

6.  Myelodysplastic syndrome presenting as generalized granulomatous dermatitis.

Authors:  Samuel J Balin; David A Wetter; Paul J Kurtin; Louis Letendre; Mark R Pittelkow
Journal:  Arch Dermatol       Date:  2011-03

7.  Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis.

Authors:  C Perrin; J P Lacour; J Castanet; J F Michiels
Journal:  Am J Dermatopathol       Date:  2001-08       Impact factor: 1.533

8.  Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.

Authors:  April Deng; Valerie Harvey; Bahram Sina; David Strobel; Ashraf Badros; Jacqueline M Junkins-Hopkins; Allen Samuels; Mana Oghilikhan; Anthony Gaspari
Journal:  Arch Dermatol       Date:  2006-02

9.  The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease.

Authors:  P Chu; M K Connolly; P E LeBoit
Journal:  Arch Dermatol       Date:  1994-10

10.  Interstitial granulomatous dermatitis associated with darifenacin.

Authors:  Holly R Mason; Jil K Swanson; Jonhan Ho; Timothy J Patton
Journal:  J Drugs Dermatol       Date:  2008-09       Impact factor: 2.114

View more
  1 in total

1.  A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report.

Authors:  Alexander B Aria; Leon Chen; Auris O Huen
Journal:  SAGE Open Med Case Rep       Date:  2018-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.